In a retrospective study, LMW heparin was shown selectively to reduce plasma IL-6 concentrations, but not concentrations of IL-2, TNF-α, IL-4, IL-10 or IFN-γ in patients with COVID-19 [113]. Here, IL6 is linked to COVID-19.